Raxatrigine hydrochloride

N/A

Report date: 2025/12/02 15:15:52
NME

Base Information

Drug NameRaxatrigine hydrochloride
Drug Alias Nameraxatriginum拉沙曲静瑞沙曲近raxatrigineraxatrigina +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type III alpha subunit blockersSodium channel protein type IX alpha subunit blockersMonoamine oxidase B inhibitors +[4] 
TargetsMonoamine oxidase BSodium channel protein type IX alpha subunitSodium channel protein type III alpha subunit +[4] 
Therapy Area/IndicationsBipolar DisorderDiabetes MellitusErythromelalgia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[24] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Inc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderDiabetes MellitusErythromelalgia +[7] 

Other Information

ATC CodeN/A
Related LinksWikipedia